Silo Pharma, a Nasdaq-listed company, has finalized its initial Bitcoin acquisition, though the purchased amount remains undisclosed

Silo Pharma has successfully completed its initial Bitcoin purchase, aligning with its strategy of diversifying digital assets, which includes prior investments in Ethereum (ETH), RSC, and Solana (SOL). The exact purchase amount for Bitcoin has not been disclosed.